Sabine Schmatloch
3PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Feb 25, 2025
Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer and HRD-Long-term Survival of the GeparOLA Study.Peter A Fasching, Sabine Schmatloch, Jan Hauke
|Jul 11, 2023
Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial.Terence M Williams, Andreas Schneeweiss, Christian Jackisch
|Apr 04, 2023
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial.Peter A Fasching, Christopher Szeto, Carsten Denkert
Pageof 1
Frequent Collaborators
3 joint publications
Peter A Fasching
3 joint publications
Carsten Denkert
3 joint publications
Valentina Nekljudova
3 joint publications
Sibylle Loibl
3 joint publications
Andreas Schneeweiss
3 joint publications
Christian Jackisch
3 joint publications
Michael Untch
2 joint publications
Christopher W Szeto
2 joint publications
Christian Schem
2 joint publications
Marion van Mackelenbergh
